| Citation: |
LIANG Yan. Interpretation on the 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guidelines for the Management of Patients with Chronic Coronary Disease[J]. Medical Journal of Peking Union Medical College Hospital, 2024, 15(2): 312-319. DOI: 10.12290/xhyxzz.2024-0043
|
| [1] |
Fihn S D, Gardin J M, Abrams J, et al. 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines, and the American College of Physicians, American Associa-tion for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons[J]. Circulation, 2012, 126(25): e354-e471.
|
| [2] |
Fihn S D, Blankenship J C, Alexander K P, et al. 2014 ACC/AHA/AATS/PCNA/SCAI/STS focused update of the guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, and the American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons[J]. Circulation, 2014, 130(19): 1749-1767. DOI: 10.1161/CIR.0000000000000095
|
| [3] |
Virani S S, Newby L K, Arnold S V, et al. 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA guideline for the manage-ment of patients with chronic coronary disease: a report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines[J]. Circulation, 2023, 148(9): e9-e119.
|
| [4] |
Knuuti J, Wijns W, Saraste A, et al. 2019 ESC guidelines for the diagnosis and management of chronic coronary syndromes[J]. Eur Heart J, 2020, 41(3): 407-477. DOI: 10.1093/eurheartj/ehz425
|
| [5] |
Patel K K, Spertus J A, Arnold S V, et al. Ischemia on PET MPI May identify patients with improvement in angina and health status post-revascularization[J]. J Am Coll Cardiol, 2019, 74(13): 1734-1736. DOI: 10.1016/j.jacc.2019.06.074
|
| [6] |
Patel K K, Spertus J A, Chan P S, et al. Myocardial blood flow reserve assessed by positron emission tomography myocardial perfusion imaging identifies patients with a survival benefit from early revascularization[J]. Eur Heart J, 2020, 41(6): 759-768. DOI: 10.1093/eurheartj/ehz389
|
| [7] |
Heitner J F, Kim R J, Kim H W, et al. Prognostic value of vasodilator stress cardiac magnetic resonance imaging: a multicenter study with 48 000 patient-years of follow-up[J]. JAMA Cardiol, 2019, 4(3): 256-264. DOI: 10.1001/jamacardio.2019.0035
|
| [8] |
Kwong R Y, Ge Y, Steel K, et al. Cardiac magnetic resonance stress perfusion imaging for evaluation of patients with chest pain[J]. J Am Coll Cardiol, 2019, 74(14): 1741-1755. DOI: 10.1016/j.jacc.2019.07.074
|
| [9] |
Al-Lamee R, Thompson D, Dehbi H M, et al. Percutane-ous coronary intervention in stable angina (ORBITA): a double-blind, randomised controlled trial[J]. Lancet, 2018, 391(10115): 31-40. DOI: 10.1016/S0140-6736(17)32714-9
|
| [10] |
REYNOLDS H R, SHAW L J, MIN J K, et al. Correction to: outcomes in the ISCHEMIA trial based on coronary artery disease and ischemia severity[J]. Circulation, 2022, 146(1): 1024-1038.
|
| [11] |
Rees K, Takeda A, Martin N, et al. Mediterranean-style diet for the primary and secondary prevention of cardiova-scular disease[J]. Cochrane Database Syst Rev, 2019, 3(3): CD009825.
|
| [12] |
Tapsell L C, Neale E P. The effect of interdisciplinary interventions on risk factors for lifestyle disease: a literature review[J]. Health Educ Behav, 2016, 43(3): 271-285. DOI: 10.1177/1090198115601092
|
| [13] |
Hall K S, Hyde E T, Bassett D R, et al. Systematic review of the prospective association of daily step counts with risk of mortality, cardiovascular disease, and dysglycemia[J]. Int J Behav Nutr Phys Act, 2020, 17(1): 78. DOI: 10.1186/s12966-020-00978-9
|
| [14] |
Ference B A, Ginsberg H N, Graham I, et al. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel[J]. Eur Heart J, 2017, 38(32): 2459-2472. DOI: 10.1093/eurheartj/ehx144
|
| [15] |
Kosiborod M, Cavender M A, Fu A Z, et al. Lower risk of heart failure and death in patients initiated on sodium-glucose cotransporter-2 inhibitors versus other glucose-lowering drugs: the CVD-REAL study (comparative effectiveness of cardiovascular outcomes in new users of sodium-glucose cotransporter-2 inhibitors)[J]. Circulation, 2017, 136(3): 249-259. DOI: 10.1161/CIRCULATIONAHA.117.029190
|
| [16] |
Sattar N, Lee M M Y, Kristensen S L, et al. Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials[J]. Lancet Diabetes Endocrinol, 2021, 9(10): 653-662. DOI: 10.1016/S2213-8587(21)00203-5
|
| [17] |
Yoshida Y, Cheng X, Shao H, et al. A systematic review of cost-effectiveness of sodium-glucose cotransporter inhibitors for type 2 diabetes[J]. Curr Diab Rep, 2020, 20(4): 12. DOI: 10.1007/s11892-020-1292-5
|
| [18] |
Gaziano J M, Brotons C, Coppolecchia R, et al. Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomised, double-blind, placebo-controlled trial[J]. Lancet, 2018, 392(10152): 1036-1046. DOI: 10.1016/S0140-6736(18)31924-X
|
| [19] |
Lopes R D, Hong H, Harskamp R E, et al. Optimal antithrombotic regimens for patients with atrial fibrillation undergoing percutaneous coronary intervention: an updated network meta-analysis[J]. JAMA Cardiol, 2020, 5(5): 582-589. DOI: 10.1001/jamacardio.2019.6175
|
| [20] |
Lopes R D, Hong H, Harskamp R E, et al. Safety and efficacy of antithrombotic strategies in patients with atrial fibrillation undergoing percutaneous coronary intervention: a network meta-analysis of randomized controlled trials[J]. JAMA Cardiol, 2019, 4(8): 747-755. DOI: 10.1001/jamacardio.2019.1880
|
| [21] |
Bonaca M P, Bhatt D L, Cohen M, et al. Long-term use of ticagrelor in patients with prior myocardial infarction[J]. N Engl J Med, 2015, 372(19): 1791-1800. DOI: 10.1056/NEJMoa1500857
|
| [22] |
Bhatt D L, Eikelboom J W, Connolly S J, et al. Role of combination antiplatelet and anticoagulation therapy in diabetes mellitus and cardiovascular disease: insights from the COMPASS trial[J]. Circulation, 2020, 141(23): 1841-1854. DOI: 10.1161/CIRCULATIONAHA.120.046448
|
| [23] |
Steffel J, Eikelboom J W, Anand S S, et al. The COMPASS trial: net clinical benefit of low-dose rivaroxaban plus aspirin as compared with aspirin in patients with chronic vascular disease[J]. Circulation, 2020, 142(1): 40-48. DOI: 10.1161/CIRCULATIONAHA.120.046048
|
| [24] |
Dargie H J. Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the Capricorn randomised trial[J]. Lancet, 2001, 357(9266): 1385-1390. DOI: 10.1016/S0140-6736(00)04560-8
|
| [25] |
Park C S, Yang H M, Ki Y J, et al. Left ventricular ejection fraction 1 year after acute myocardial infarction identifies the benefits of the long-term use of β-blockers: analysis of data from the KAMIR-NIH registry[J]. Circ Cardiovasc Interv, 2021, 14(4): e010159. DOI: 10.1161/CIRCINTERVENTIONS.120.010159
|
| [26] |
Sorbets E, Steg P G, Young R, et al. β-Blockers, calcium antagonists, and mortality in stable coronary artery disease: an international cohort study[J]. Eur Heart J, 2019, 40(18): 1399-1407. DOI: 10.1093/eurheartj/ehy811
|
| [1] | LI Zhewei, SHI Qianling, LIU Hui, LUO Xufei, WANG Zijun, TIAN Jinhui, GE Long, CHEN Yaolong, Methodology and Technology Specialisation Committee of the STAR Working Group. STAR Guideline Terminology (I): Planning and Launching[J]. Medical Journal of Peking Union Medical College Hospital, 2025, 16(1): 216-223. DOI: 10.12290/xhyxzz.2024-1076 |
| [2] | ZHU Di, LI Haodong, WANG Zijun, SHI Qianling, LIU Hui, QIN Yishan, YAO Yuanyuan, LI Zhewei, HE Hongfeng, TIAN Jinhui, GE Long, CHEN Yaolong, Methodology and Technology Specialisation Committee of the STAR Working Group. STAR Guideline Terminology(Ⅱ):Clinical Question Formulation, Evidence Retrieval and Appraisal, and Recommendation Development[J]. Medical Journal of Peking Union Medical College Hospital. DOI: 10.12290/xhyxzz.2025-0169 |
| [3] | WANG Zhaojian, MA Xuda, XIE Jiangmiao, ZOU Kun, LONG Xiao. Protocol for the Development of Chinese Guideline for the Diagnosis and Management of Localized Scleroderma[J]. Medical Journal of Peking Union Medical College Hospital, 2024, 15(6): 1311-1317. DOI: 10.12290/xhyxzz.2024-0656 |
| [4] | TIAN Zhuang, ZHANG Shuyang. Interpretation on Chinese Guidelines for the Diagnosis and Treatment of Heart Failure 2024[J]. Medical Journal of Peking Union Medical College Hospital, 2024, 15(4): 801-806. DOI: 10.12290/xhyxzz.2024-0292 |
| [5] | WEN Qiang, WANG Renfei, HUANG Rui, ZHANG Yuelun, LIN Yansong, Chinese Society of Clinical Oncology Nuclear Medicine Expert Committee. Guidelines for the Diagnosis, Treatment, and Management of Iodine Refractory Differentiated Thyroid Cancer(2023 edition)[J]. Medical Journal of Peking Union Medical College Hospital, 2023, 14(6): 1197-1202. DOI: 10.12290/xhyxzz.2023-0342 |
| [6] | ZUO Wei, LIU Rongji, SUN Yajia, ZHANG Bo, CHEN Yaolong, ZHANG Shuyang. Interpretation on Management Guideline for the Off-label Use of Drugs in China(2021 Edition)[J]. Medical Journal of Peking Union Medical College Hospital, 2023, 14(1): 86-93. DOI: 10.12290/xhyxzz.2022-0588 |
| [7] | Joint Surgery Branch of Chinese Orthopaedic Association, Joint Surgery Branch of Beijing Orthopaedic Association. Guidelines for Perioperative Pain Management in Total Knee Arthroplasty in China (2022)[J]. Medical Journal of Peking Union Medical College Hospital, 2022, 13(6): 965-985. DOI: 10.12290/xhyxzz.2022-0642 |
| [8] | XU Shengyong, XU Jun, ZHU Huadong, YU Xuezhong. Strengthen the Management of Difficult Airway and Improve the Treatment of Clinical Practice: Interpretation on 2022 American Society of Anesthesiologists Practice Guidelines for Management of the Difficult Airway[J]. Medical Journal of Peking Union Medical College Hospital, 2022, 13(3): 427-432. DOI: 10.12290/xhyxzz.2022-0133 |
| [9] | WANG Lin, SONG Hongmei. Interpretation on Chinese Guidelines for the Diagnosis and Treatment of Childhood-onset Systemic Lupus Erythematosus[J]. Medical Journal of Peking Union Medical College Hospital, 2022, 13(3): 412-420. DOI: 10.12290/xhyxzz.2022-0018 |
| [10] | WU Wenming, CHEN Jie, BAI Chunmei, YIHEBALI Chi, DU Yiqi, FENG Shiting, HUO Li, JIANG Yuxin, LI Jingnan, LOU Wenhui, LUO Jie, SHAO Chenghao, SHEN Lin, WANG Feng, WANG Liwei, WANG Ou, WANG Yu, WU Huanwen, XING Xiaoping, XU Jianming, XUE Huadan, XUE Ling, YANG Yang, YU Xianjun, YUAN Chunhui, ZHAO Hong, ZHU Xiongzeng, ZHAO Yupei, Chinese Pancreatic Surgery Association, Chinese Society of Surgery, Chinese Medical Association. The Chinese Guidelines for the Diagnosis and Treatment of Pancreatic Neuroendocrine Neoplasms (2020)[J]. Medical Journal of Peking Union Medical College Hospital, 2021, 12(4): 460-480. DOI: 10.12290/xhyxzz.2021-0481 |
| 1. |
李露，王静，张解军. 增强双期CT成像参数联合血清癌胚抗原对肺亚厘米结节良恶性的预测价值. 中国医药导报. 2023(19): 162-165 .
| |
| 2. |
谢青，任彤，邹珏，赵瑞芬. 原发性肺黏液腺癌的CT和MRI表现. 中国医学影像学杂志. 2022(08): 790-794 .
|
Supported by: Beijing Renhe Information Technology Co., Ltd. 
Submit
Review
Office
Email Alert
RSS
DownLoad: